1-8 of 8
M.V. Mateos
Close
Sort by
Journal Articles

Maintenance Treatment after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) in Multiple Myeloma (MM) with a Unique Weekly Dose of Pegylated Interpheron alpha2b (Pegintron®): Preliminary Clinical Results in 30 Patients of a Phase II Multicentric Study.

Adrian Alegre, B. Aguado, J. Garcia-Laraña, J.J. Lahuerta, M.V. Mateos, R. Rodriguez-Notario, B. Navas, J.M. Fernandez-Rañada, J.F. San Miguel
Journal: Blood
Blood (2007) 110 (11): 4822.
https://doi.org/10.1182/blood.V110.11.4822.4822
Published: 2007
Journal Articles

Non Myeloablative Allogeneic Related Transplant in Patients with Aggressive B Cell Lymphoma: Results of Two Multicenter Spanish Trials. The GELTAMO Group.

M.D. Caballero, J. Briones, M.V Mateos, J.F. Tomás, R. Martino, J. de la Serna, J.L. Díez, J.A. Pérez-Simón, A. Sureda, J. Sarrá, J. García-Laraña, J.M. Ribera, J. Sierra, J.F. San Miguel
Journal: Blood
Blood (2007) 110 (11): 5053.
https://doi.org/10.1182/blood.V110.11.5053.5053
Published: 2007
Journal Articles

Clinical Efficacy of Bortezomib Based Therapy in Plasma Cell Leukemias.

Adrian Alegre, B. Aguado, J.J. Lahuerta, C. Cervero, A. Oriol, A. Abella, R. Carrion, R. Renat, J.A. Hernandez-Rivas, J. de la Rubia, M.V. Mateos, R. Garcia-Sanz, R. Rodriguez-Notario, B. Navas, J.M. Fernandez-Rañada, J.F. San Miguel
Journal: Blood
Blood (2007) 110 (11): 2726.
https://doi.org/10.1182/blood.V110.11.2726.2726
Published: 2007
Journal Articles

A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma (MM) Patients.

M.V. Mateos, M. Hernández, J. Díaz Mediavilla, L. Palomera, M.J. Moro, J. Hernández, J.J. Lahuerta, J. De la Rubia, M.J. Terol, A. Sureda, J. Bargay, F. Arriba, A. Alegre, P. Rivas, J. García-Laraña, J.M. Ribera, D. Carrera, J. Bladé, F. Prósper, D.L. Esseltine, H. van de Velde, D. Schenkein, J.F. San Miguel
Journal: Blood
Blood (2005) 106 (11): 786.
https://doi.org/10.1182/blood.V106.11.786.786
Published: 2005
Journal Articles

Allogeneic Transplant in Patients with Poor Prognosis B-Chronic Lymphocytic Leukemia (B-CLL): Comparative Study between Myeloablative(M) and Non-Myeloablative(NM) Conditioning Regimen.

M.D. Caballero, J.A. García-Marco, R. Martino, J. Esteve, M.V. Mateos, A. León, J. Sarrá, Josep Maria Ribera, G. Sanz, J. de la Serna, J.L. Díez, J.F. San Miguel11
Journal: Blood
Blood (2004) 104 (11): 2306.
https://doi.org/10.1182/blood.V104.11.2306.2306
Published: 2004
Journal Articles

Non Myeloablative Transplant in Patients with Indolent Non-Hodgkin’s Lymphoma (NHL): Results of Two Prospectives Multicenter Trials.

M.D. Caballero, R. Martino, M.V. Mateos, J. Briones, J. de la Serna, J.F. Tomas, R. Arranz, J.L. Diez, V. Rubio, Josep Maria Ribera, J.M. Moraleda, G. Sanz, A. Urbano, J. Sarrá, A. Sampol, J. Sierra
Journal: Blood
Blood (2004) 104 (11): 2318.
https://doi.org/10.1182/blood.V104.11.2318.2318
Published: 2004
Journal Articles

Allogeneic Transplant with Reduced Intensity Conditioning Regimens (RIC) Could Reverse Poor Prognosis of Unmutated Igvh, 11q- or 17p- Abnormalities in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

M.D. Caballero, J.A. García-Marco, R. Martino, M.V. Mateos, R. Cabrera, J. Briones, M. González, J. Esteve, A. León, Josep Maria Ribera, J. Sarrá, J. de la Serna, J.F. San Miguel
Journal: Blood
Blood (2004) 104 (11): 2319.
https://doi.org/10.1182/blood.V104.11.2319.2319
Published: 2004
Journal Articles

A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma Patients.

M.V. Mateos, Joan Blade, J. Diaz Mediavilla, J.J. Lahuerta, M.J. Terol, J. Hernández, M.J. Moro, J. Bargay, J.M. Ribera, J. de la Rubia, A. Sureda, D. Carrera, F. de Arriba, L. Palomera, M. Hernández, J. García Laraña, A. Alegre, F. Prosper, P. Rivas, D.L. Esseltine, D. Schenkein, J.F. San Miguel
Journal: Blood
Blood (2004) 104 (11): 3462.
https://doi.org/10.1182/blood.V104.11.3462.3462
Published: 2004